Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-03-01 @ 4:13 PM
Study NCT ID:
NCT02185794
Status:
COMPLETED
Last Update Posted:
2020-09-17
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection
Sponsor:
Gilead Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C Virus Infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Sustained Virologic Response | View |
| None | Direct Acting Antiviral | View |
| None | Combination Therapy | View |
| None | Liver Diseases | View |
| None | Digestive System Diseases | View |
| None | Hepatitis, Viral, Human | View |
| None | Enterovirus Infections | View |
| None | Picornaviridae Infections | View |
| None | RNA Virus Infections | View |
| None | Flaviviridae Infections | View |
| None | Antiviral Agents | View |
| None | Anti-Infective Agents | View |
| None | Therapeutic Uses | View |
| None | Pharmacologic Actions | View |
| None | Antimetabolites | View |
| None | Molecular Mechanisms of Pharmacological Action | View |